MLchartDataset catalogue

CP-609,754

Term · Oncology and biomedicine · MLC-T-ONC-002113

  1. A substance that is being studied in the treatment of cancer.

  2. A quinolinone derivative that inhibits farnesyl protein transferase, an enzyme that mediates the farnesylation of RAS, causing possible inhibition of the RAS pathway.

Table 1. Record
IdentifierMLC-T-ONC-002113
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-002113",
  "term": "CP-609,754",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A substance that is being studied in the treatment of cancer.",
    "A quinolinone derivative that inhibits farnesyl protein transferase, an enzyme that mediates the farnesylation of RAS, causing possible inhibition of the RAS pathway."
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/cp-609754/"
}

Record 5,392 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.